Broadwood boosts STAAR Surgical (STAA) stake in Form 4 filing report
Rhea-AI Filing Summary
Broadwood Partners, L.P., a 10% owner of STAAR Surgical, reported buying 27,485 shares of common stock on January 9, 2026 at a weighted average price of $22.0534 per share, bringing its directly owned stake to 15,453,629 shares.
These shares are held by Broadwood Partners and may be deemed indirectly beneficially owned by Broadwood Capital, Inc. and its president, Neal C. Bradsher, who also directly owns 25,900 shares of STAAR Surgical common stock.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did STAA report in this Form 4?
The filing reports that Broadwood Partners, L.P. bought 27,485 shares of STAAR Surgical common stock on January 9, 2026 at a weighted average price of $22.0534 per share.
Who is the primary owner of the STAAR Surgical (STAA) shares in this filing?
The reported securities are directly owned by Broadwood Partners, L.P., which is identified as a 10% owner of STAAR Surgical.
How many STAAR Surgical shares does Broadwood Partners hold after the transaction?
After the reported purchase, Broadwood Partners, L.P. beneficially owns 15,453,629 shares of STAAR Surgical common stock.
What role do Broadwood Capital, Inc. and Neal C. Bradsher play in this STAA Form 4?
Broadwood Capital, Inc. is the general partner of Broadwood Partners, and Neal C. Bradsher is president of Broadwood Capital. The filing states they may be deemed to indirectly beneficially own the Broadwood Partners shares, subject to their pecuniary interest.
Does Neal C. Bradsher personally own STAAR Surgical (STAA) shares?
Yes. The filing notes that 25,900 shares of STAAR Surgical common stock are directly owned by Neal C. Bradsher.
What does the weighted average price in the STAA insider purchase mean?
The filing explains that the $22.0534 figure is a weighted average purchase price, with individual trade prices ranging from $21.965 to $22.09.
Do the reporting persons admit full beneficial ownership of all STAA shares reported?
No. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest, and the filing states it is not an admission of beneficial ownership for legal purposes.